RDY · Dr Reddys Laboratories Ltd · Documents

$14.15 +0.40 (+2.91%) At close · Oct 28 Q2 2026 earnings call transcript

Market Cap

$11.73B

833.07M

Volume · Oct 28 4.47M Avg daily vol (3M) 2.92M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2020-06-17	—
6-K	—	2020-06-16	—
6-K	—	2020-06-15	2020-06-13
20-F	—	2020-06-15	2020-03-31
6-K	—	2020-06-15	2020-06-12
6-K	—	2020-06-10	—
6-K	—	2020-06-01	2020-05-30
6-K	—	2020-05-28	—
6-K	—	2020-05-22	2020-05-21
6-K	—	2020-05-21	2020-05-20
6-K	—	2020-05-21	2020-05-20
6-K	—	2020-05-18	2020-05-16
6-K	—	2020-05-13	—
6-K	—	2020-05-08	2020-05-07
6-K	—	2020-05-08	—
6-K	—	2020-05-07	2020-05-06
6-K	—	2020-05-06	—
6-K	—	2020-05-01	—
6-K	—	2020-04-29	—
6-K	—	2020-04-27	—
6-K	—	2020-04-14	—
6-K	—	2020-04-10	2020-04-09
6-K	—	2020-03-27	—
6-K	—	2020-03-23	—
6-K	—	2020-03-20	—
6-K	—	2020-03-19	—
6-K	—	2020-03-17	—
6-K	—	2020-03-16	2020-03-14
6-K	—	2020-03-12	—
6-K	—	2020-03-05	—
6-K	—	2020-03-02	2020-02-28
6-K	—	2020-02-27	—
6-K	—	2020-02-20	—
6-K	—	2020-02-18	2020-02-16
6-K	—	2020-02-14	—
6-K	—	2020-02-12	—
6-K	—	2020-02-07	—
6-K	—	2020-01-31	—
6-K	—	2020-01-30	2020-01-28
6-K	—	2020-01-29	—
6-K	—	2020-01-27	—
6-K	—	2020-01-27	—
6-K	—	2020-01-13	—
6-K	—	2020-01-10	—
6-K	—	2020-01-03	—

Showing 701–745 of 745 filings

Key facts CIK 1135951 CUSIP 256135203 13F (30d) 56 filings 51 filers Visit website Investor relations